Table 3.
Summary of changes in vision before RTX treatment.
| Vision | ||
|---|---|---|
| Right | Left | |
| Patient 1 | ||
| Before high-dose GCs pulse treatment | 0.3 | 0.08 |
| After 7 times high-dose GCs pulse treatment | 0.1 | 0.1 |
| After bilateral orbital decompression and the eighth high-dose GCs pulse treatment (before RTX) | 0.5 | 0.6 |
| Patient 2 | ||
| Before high-dose GCs pulse treatment combined with right orbital radiotherapy | 1.0 | 1.0 |
| After high-dose GCs pulse treatment combined with right orbital radiotherapy | 1.2 | 1.2 |
| Disease relapse | 0.1 | 1.0 |
| After right orbital decompression (before RTX) | 0.4 | 1.0 |
RTX, rituximab; GCs, glucocorticoids.